Depression/anxiety problems increased for urban, racial- and ethnic-minority children during versus six months before the pandemic

Reasons reported for cannabis use similar for prepregnancy and lactation periods with emphasis on symptom management during pregnancy

Findings seen for COVID-19 infection, hospitalization, and mortality

Screening protocol could identify candidates for neuromodulation therapies who could skip a formal in-person psychological assessment

Three-month depressive symptoms in adolescents lower with online SSIs compared with supportive control during COVID-19 pandemic

Sharp increase in deaths in Midwestern, Southern, Western jurisdictions; stimulant also involved in about four of 10 IMF-involved deaths

Pediatricians should inquire about child and family functioning; office visits should integrate behavioral, mental health surveillance

Elevated resting heart rate also associated with accelerated cognitive decline

Rare genetic variants occur more frequently in severe, extremely treatment-resistant schizophrenia versus typical schizophrenia

Amyloid-related imaging abnormalities-edema seen on brain MRI most common adverse event in participants receiving high-dose aducanumab